Comparison of ventilator-associated pneumonia (VAP) rates between different ICUs: Implications of a zero VAP rate

Journal of Critical Care

Volumn 27, Issue 1, 2012, Pages 26-32

  Sundar, Krishna M ^a   Nielsen, David ^b   Sperry, Paul ^c  

^a UNIVERSITY OF UTAH   (United States)

^b UTAH VALLEY REGIONAL MEDICAL CENTER   (United States)

^c BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

Mechanical ventilation; Outcomes assessment; Pneumonia, ventilator associated; Treatment outcome

Indexed keywords

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGE; AGED; APACHE; ARTICLE; ARTIFICIAL VENTILATION; CLOSTRIDIUM DIFFICILE; COMMUNITY HOSPITAL; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DIALYSIS; DISEASE SEVERITY; FEMALE; GENDER; HEALTH CARE QUALITY; HEALTH PROGRAM; HOSPITAL BED CAPACITY; HUMAN; ICU BED NUMBER; INFECTION RATE; INTENSIVE CARE; INTENSIVE CARE UNIT; INTERMOUNTAIN INTENSIVE MEDICINE PROGRAM CRITERIA; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROSURGERY; ORGAN TRANSPLANTATION; PATIENT TRANSPORT; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE; TRACHEOSTOMY; VENTILATOR ASSOCIATED PNEUMONIA; VENTILATOR BUNDLE;

ADULT; AGED; CROSS INFECTION; FEMALE; HEALTH FACILITIES; HOSPITAL BED CAPACITY, 100 TO 299; HOSPITAL BED CAPACITY, 300 TO 499; HOSPITALS, COMMUNITY; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; RETROSPECTIVE STUDIES; UTAH;

EID: 84856481501     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2011.05.019     Document Type: Article

References (35)

1. Berwick D.M., Calkins D.R., McCannon C.J., Hackbarth A.D. The 100, 0000 lives campaign: setting a goal and a deadline for improving health care quality. JAMA 2006, 295:324-327.
2. Blamoun J., Alfakir M., Rella M.E., et al. Efficacy of an expanded ventilator bundle for the reduction of ventilator-associated pneumonia in the medical intensive care unit. Am J Infect Control 2009, 37:172-175.
3. Zaydfudim V., Dossett L.A., Starmer J.M., et al. Implementation of a real-time compliance dashboard to help reduce SICU ventilator-associated pneumonia with the ventilator bundle. Arch Surg 2009, 144:656-662.
4. Safdar N., Dezfulian C., Collard H.R., Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 2005, 33.
5. Chastre J. Conference summary: Ventilator-associated pneumonia. Respir Care 2005, 50:975-983.
6. Klompas M. Prevention of ventilator-associated pneumonia. Expert Rev Anti Infect Ther 2010, 8:791-800.
7. Conway Morris A., Kefala K., Simpson A.J., et al. Evaluation of the effect of diagnostic methodology on the reported incidence of ventilator-associated pneumonia. Thorax 2009, 64:516-522.
8. Klompas M. Inter-observer variability in ventilator-associated pneumonia surveillance. Am J Infect Control 2010, 38:237-239.
9. Kollef M.H. Review of recent clinical trials of hospital-acquired pneumonia and ventilator-associated pneumonia: a perspective from academia. Clin Infect Dis 2010, 51(Suppl 1):S29-S35.
10. Klompas M. Unintended consequences in the drive for zero. Thorax 2009, 64:463-465.
11. Kollef M.H., Micek S.T. Using protocols to improve patient outcomes in the intensive care unit: focus on mechanical ventilation and sepsis. Semin Respir Crit Care Med 2010, 19-29.
12. Morrow L.E., Kollef M.H. Recognition and prevention of nosocomial pneumonia in the intensive care unit and infection control in mechanical ventilation. Crit Care Med 2010, 38(Suppl):S352-S362.
13. Muscedere J.G., Martin C.M., Heyland D.K. The impact of ventilator-associated pneumonia on the Canadian health care system. J Crit Care 2008, 23:5-10.
14. Horan T.C., Andrus M., Dudeck M.A. CDC/NHSN surveillance definition of health-care associated infection and criteria for specific types of infection in the acute care setting. Am J Infect Control 2008, 36:309-332.
15. A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med 2006, 355:2619-2630. The Canadian Critical Care Trials Group.
16. Safdar N., Crnich C.J., Maki D.G. The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention. Respir Care 2005, 50:725-739.
17. Koeman M., van der Ven A.J., Hak E., et al. Oral decontamination with chlorhexidine reduces the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med 2006, 173:1348-1355.
18. Dezfulian C., Shojania K., Collard H.R., Matthay M.A., Saint S. Subglottic secretion drainage for preventing ventilator-associated pneumonia: a meta-analysis. Am J Med 2005, 118:11-18.
19. Kollef M.H., Afessa B., Anzeuto A., et al. Silver-coated endotracheal tubes and the incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA 2008, 300:805-813.
20. Lorente L., Lecuona M., Jimenez A., Mora M.L., Sierra A. Influence of an endotracheal tube with polyurethane cuff and subglottic secretion drainage on pneumonia. Am J Respir Crit Care Med 2007, 176:1079-1083.
21. Zilbeberg M.D., Shorr A.F., Kollef M.H. Implementing quality improvements in the intensive care unit: ventilator bundle as an example. Crit Care Med 2009, 37:305-309.
22. Kress J.P., Pohlman A.S., O'Connor M.F., Hall J.B. Daily interruption of sedative infusion in critically ill patients undergoing mechanical ventilation. N Engl J Med 2000, 342:1471-1477.
23. Acute Respiratory Distress Syndrome network Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000, 342:1301-1308.
24. Hortal J., Giannella M., Perez M.J., et al. Incidence and risk factors for ventilator-associated pneumonia after major heart surgery. Intensive Care Med 2009, 35:1518-1525.
25. Cook D.J., Reeve B.K., Guyatt G.H., et al. Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. JAMA 1996, 275:308-314.
26. Dubose J., Teixeira P.G., Inaba K., et al. Measurable outcomes of quality improvement using a daily rounds checklist: one-year analysis in a trauma intensive care unit with sustained ventilator-associated pneumonia reduction. J Trauma 2010, 69:855-860.
27. Gursel G., Demirtas S. Value of APACHE II, SOFA and CPIS scores in predicting prognosis in patients with ventilator-associated pneumonia. Respiration 2006, 73:503-508.
28. Ranes J.L., Gordon S.M., Chen P., Fatica C., Hammel J., Gonzales J.P., et al. Predictors of long-term mortality in patients with ventilator-associated pneumonia. Am J Med 2006, 897:e13-e19.
29. Kollef M.H., Morrow L.E., Niederman M.S., Leeper K.V., Anzeuto A., Benz-Scott L., et al. Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest 2006, 129:1210-1218.
30. Klompas M. The paradox of ventilator-associated pneumonia prevention measures. Crit Care 2009, 13:315. 10.1186/cc8036).
31. Bird D., Zambuto A., O'Donnell C., et al. Adherence to ventilator-associated pneumonia bundle and incidence of ventilator-associated pneumonia in the surgical intensive care unit. Arch Surg 2010, 145:465-470.
32. Kollef M.H., Silver P., Murphy D.M., Trovillion E. The effect of late-onset ventilator-associated pneumonia in determining patient mortality. Chest 1995, 108:1655-1662.
33. Gacouin A., Barbarot N., Camus C., et al. Late-onset ventilator-associated pneumonia in nontrauma intensive care unit patients. Anesth Analg 2009, 109:1584-1590.
34. Heyland D.K., Cook D.J., Griffith L., Keenan S.P., Brun-Buisson C. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med 1999, 159:1249-1256.
35. Morris P.E., Munro C.L. All ICUs are not created equal: evaluating pilot studies performed in different environments. Am J Crit Care 2009, 18:294-297.